KOJINTX Trademark
Trademark Overview
On Wednesday, May 1, 2024, a trademark application was filed for KOJINTX with the United States Patent and Trademark Office. The USPTO has given the KOJINTX trademark a serial number of 98528840. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Friday, November 15, 2024. This trademark is owned by Kojin Therapeutics, Inc.. The KOJINTX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
research and development of therapeutics for the treatment of cancer, asthma and inflammatory diseases, autoimmune diseases, cardiovascular diseases, liver diseases, degenerative diseases, infectious diseases, allergies, central nervous system diseases, and renal diseases; providing scientific research information in the field of therapeutics for the treatment of cancer, asthma and inflammatory diseases, autoimmune diseases, cardiovascular diseases, liver diseases, degenerative diseases, infectious diseases, allergies, central nervous system diseases, and renal diseases
General Information
| Serial Number | 98528840 |
| Word Mark | KOJINTX |
| Filing Date | Wednesday, May 1, 2024 |
| Status | 638 - NEW APPLICATION - ASSIGNED TO EXAMINER |
| Status Date | Friday, November 15, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Description of Mark | The mark consists of the word "Kojin" together with the letters "TX" in superscript, all in orange.. |
| Pseudo Mark | KOJIN TX |
| Indication of Colors claimed | The color(s) orange is/are claimed as a feature of the mark. |
| Goods and Services | research and development of therapeutics for the treatment of cancer, asthma and inflammatory diseases, autoimmune diseases, cardiovascular diseases, liver diseases, degenerative diseases, infectious diseases, allergies, central nervous system diseases, and renal diseases; providing scientific research information in the field of therapeutics for the treatment of cancer, asthma and inflammatory diseases, autoimmune diseases, cardiovascular diseases, liver diseases, degenerative diseases, infectious diseases, allergies, central nervous system diseases, and renal diseases |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, May 1, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | Sunday, May 31, 2020 |
| First Use In Commerce Date | Wednesday, September 30, 2020 |
Trademark Owner History
| Party Name | Kojin Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Boston, MA 02210 |
Trademark Events
| Event Date | Event Description |
| Wednesday, May 1, 2024 | NEW APPLICATION ENTERED |
| Sunday, October 27, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, November 15, 2024 | ASSIGNED TO EXAMINER |
